Gedeon Richter and Myovant Sciences Enter into Exclusive License Agreement to Commercialize Relugolix Combination Tablet for Uterine Fibroids and Endometriosis in Certain Territories Outside the U.S.
3/31/2020
Business related Licence-in Women's Healthcare PARTNER - MYOVANT PRODUCT - RYEQO